Article
The Many Uses of p53 Immunohistochemistry in Gynecological Pathology: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual9 Meeting.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists - 1 Jan 2021
Köbel Martin, Kang Eun Young
Abstract excerpt
Ancillary immunohistochemistry (IHC) has become a reliable adjunct for subclassification of gynecological neoplasms. An important recent development was optimization and validation of p53 IHC, where 3 abnormal IHC patterns (nuclear overexpression, complete absence, cytoplasmic) were shown to predict underlying TP53 mutations with high accuracy in ovarian carcinomas. p53 IHC now helps in distinguishing high-grade...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
